4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2019 / Systematic review of clinical studies
A systematic review evaluated 135 clinical studies from China comprising 9,474 cancer treatment cases involving the shiitake polysaccharide lentinan. Most cases involved lung (3,469), gastric (3,039), or colorectal (1,646) malignancies. Across evaluated reports, lentinan use was linked to better quality of life and greater efficacy of concurrent chemotherapy or radiation treatment.
Zhang M, Zhang Y, Zhang L, et al. Prog Mol Biol Transl Sci, 2019. PMID 31030752
2012 / Meta-analysis of randomized controlled trials
A meta-analysis of five randomized trials examined Ganoderma lucidum in cancer care. Combining the mushroom with chemotherapy or radiotherapy increased the likelihood of a positive response compared to conventional therapy alone (RR 1.50, 95% CI 0.90 to 2.51). Furthermore, supplementation raised CD3, CD4, and CD8 percentages by 3.91%, 3.05%, and 2.02%, while quality of life was relatively improved in four studies.
Jin X, Ruiz Beguerie J, Sze DM, et al. Cochrane Database Syst Rev, 2012. PMID 22696372
2016 / Double-blind, placebo-controlled human clinical trial
A double-blind, placebo-controlled clinical trial evaluated the immune-modulating effects of Pleurotus cornucopiae (Oyster mushroom, Tamogitake) extract ingested for 8 weeks. Intake of the extract significantly elevated serum IFN-γ (P = 0.013) and elevated IL-12, whereas serum levels of IL-10, IL-13, and other cytokines showed minimal changes. Natural killer cell activity tended to increase, but the change was not statistically significant.
Tanaka A, Nishimura M, Sato Y, et al. J Tradit Complement Med, 2016. PMID 27774430
2015 / Randomized controlled trial
Fifty-two healthy adults consumed 5 g or 10 g of dried shiitake mushrooms daily for 4 weeks in a parallel-group trial. Mushroom intake increased ex vivo proliferation of γδ-T cells by 60% and natural killer T cells twofold (both p < 0.0001), along with greater activation receptor expression. Salivary secretory immunoglobulin A increased and serum C-reactive protein decreased, accompanied by distinct shifts in cytokine secretion profiles.
Dai X, Stanilka JM, Rowe CA, et al. J Am Coll Nutr, 2015. PMID 25866155
2015 / Phase I trial
Thirty-six patients with rising prostate-specific antigen levels received escalating doses of white button mushroom powder in a phase I trial. No dose-limiting toxicities occurred, and the overall prostate-specific antigen response rate was 11%. Complete responses occurred in two patients receiving 8 and 14 g/d, with reductions to undetectable levels lasting 49 and 30 months.
Twardowski P, Kanaya N, Frankel P, et al. Cancer, 2015. PMID 25989179
2012 / Randomized controlled trial
In a randomized trial, 24 healthy adults consumed their normal diet alone or with 100 g daily of blanched white button mushrooms for one week. The mushroom group showed a significant increase in mean salivary immunoglobulin A secretion rate of 53% at week one and 56% at week two relative to week zero (P < 0.0005), returning to baseline by week three. No significant changes occurred in the control group.
Jeong SC, Koyyalamudi SR, Pang G Nutrition, 2012. PMID 22113068
2010 / Open-label study
In an open-label study, 51 patients with biochemical failure following radical prostatectomy for non-metastasized prostate cancer took either Senseiro (Agaricus blazei Murill extract, n=32) or Rokkaku Reishi (Ganoderma lucidum, n=15) for 6 months. Forty-seven patients completed the protocol and were assessed. No partial response (a 50% or greater decrease in serum PSA) was observed in any patient. Alteration of PSA doubling time did not correlate with serum testosterone levels, and no serious adverse effects were observed.
Yoshimura K, Kamoto T, Ogawa O, et al. Int J Urol, 2010. PMID 20412340
2002 / Open-label clinical trial
Sixty-two men with histologically proven prostate cancer and elevated PSA received shiitake mushroom mycelium extract capsules three times daily for 6 months. Among 61 assessable patients, zero achieved a complete or partial PSA response, 23 developed disease progression, and 38 maintained stable PSA levels. When pre-study PSA trajectories were examined, only 4 of 61 patients (7%) demonstrated stabilized disease while taking the supplement.
deVere White RW, Hackman RM, Soares SE, et al. Urology, 2002. PMID 12385925
2020 / Pooled prospective cohort study
Researchers analyzed pooled data from 36,499 Japanese men followed for a median of 13.2 years (574,397 person-years) to examine mushroom consumption and prostate cancer risk. During follow-up, 1,204 incident prostate cancer cases (3.3%) occurred. Compared to consuming mushrooms <1 time/week, consumption 1-2 times/week was associated with an HR of 0.92 (95% CI: 0.81, 1.05) and ≥3 times/week with an HR of 0.83 (95% CI: 0.70, 0.98; p-trend = 0.023). This inverse relationship was particularly apparent in men aged ≥50 years and did not differ by clinical cancer stage or intake of vegetables, fruit, meat, and dairy products.
Shows an association, not proof of cause and effect.
Zhang S, Sugawara Y, Chen S, et al. Int J Cancer, 2020. PMID 31486077
2020 / Case report
This report details a patient who developed a striking linear flagellate dermatitis without urticaria three days after returning from Tokyo, where he consumed shiitake mushrooms (Lentinula edodes). The rash resolved after two weeks following treatment with topical corticosteroids and antihistamines for symptomatic relief. Shiitake dermatitis is considered to be a toxic or hypersensitivity reaction to lentinan, a heat-inactivated polysaccharide present in the mushroom's cell walls.
Shows an association, not proof of cause and effect.
Heer RS, Patel NB, Mandal AKJ, et al. Am J Emerg Med, 2020. PMID 31864870
2019 / Prospective cohort study
This prospective study followed 68,327 women and 44,664 men for up to 26 years, documenting 22,469 incident cancer cases. In pooled multivariable analysis, participants consuming five or more servings of mushrooms per week had no significantly different risk of total cancer compared to those who almost never consumed mushrooms (HR, 1.06; 95% CI, 0.98-1.14). Mushroom consumption was not associated with 16 site-specific cancers, although a marginal positive association was observed for lung cancer (P trend = 0.05).
Shows an association, not proof of cause and effect.
Lee DH, Yang M, Keum N, et al. Cancer Prev Res (Phila), 2019. PMID 31164344
2014 / Case report
A 72-year-old Japanese female with liver cancer had ingested 4 - 5 teaspoons per day of Chaga mushroom powder for 6 months. Renal function decreased and hemodialysis was initiated. Renal biopsy showed diffuse tubular atrophy, interstitial fibrosis, and oxalate crystals detected in the tubular lumina and urinary sediment, resulting in a diagnosis of oxalate nephropathy. The authors noted that Chaga mushrooms contain extremely high oxalate concentrations.
Shows an association, not proof of cause and effect.
Kikuchi Y, Seta K, Ogawa Y, et al. Clin Nephrol, 2014. PMID 23149251
2013 / Case report
A 45-year-old gentleman presented with an intensely itchy, widespread eruption persisting for 5 days. Examination revealed a florid, erythematous, papular, flagellate rash over his trunk and limbs. He had consumed shiitake mushrooms 10 days earlier, resulting in a diagnosis of shiitake dermatitis, which settled spontaneously.
Shows an association, not proof of cause and effect.
Hamer S, Rabindranathnambi R BMJ Case Rep, 2013. PMID 23291817
2010 / Cross-sectional survey
Researchers examined the association between major dietary patterns and depressive symptoms in 521 Japanese municipal employees aged 21-67 years. Dietary patterns were derived via principal component analysis from a 52-item brief diet history questionnaire, and depressive symptoms were assessed using the CES-D scale. A healthy Japanese dietary pattern—characterized by high intakes of vegetables, fruit, mushrooms, and soy products—was associated with fewer depressive symptoms, with multivariate-adjusted odds ratios across tertiles of 1.00 (reference), 0.99 (95% CI: 0.62-1.59), and 0.44 (95% CI: 0.25-0.78; P for trend = 0.006). Other dietary patterns showed no appreciable association with depressive symptoms.
Shows an association, not proof of cause and effect.
Nanri A, Kimura Y, Matsushita Y, et al. Eur J Clin Nutr, 2010. PMID 20485303
2010 / Cross-sectional study
In the Hordaland Health Study, researchers examined the relationship between plant food intake and cognitive performance in 2,031 individuals aged 70-74 years using a validated FFQ and a cognitive test battery. Subjects with intakes above the 10th percentile for fruits, vegetables, grain products, and mushrooms performed significantly better on cognitive tests than those with very low or no intake. Strongest associations were found for combined fruit and vegetable intake up to about 500 g/d, while grain products and potatoes plateaued at 100-150 g/d, and mushroom intake showed a linear association. Among individual foods, positive associations were most pronounced for carrots, cruciferous vegetables, citrus fruits, and high-fibre bread, whereas white bread intake was negatively associated with cognition.
Shows an association, not proof of cause and effect.
Nurk E, Refsum H, Drevon CA, et al. Br J Nutr, 2010. PMID 20550741
1999 / Cross-sectional dietary exposure assessment
The FDA Total Diet Study (1991-1996) monitored arsenic levels across 261-264 foods collected from retail stores in four US regions. Arsenic (>= 0.03 ppm) was detected in 63 (24%) foods, with the highest concentrations in seafood, followed by rice/rice cereal, mushrooms, and poultry. Estimated average daily intakes ranged from 2 micrograms/day for infants to 92 micrograms/day for 60-65-year-old men. Seafood contributed 42% of intake for infants, 76-90% for children (2-10 years), 79-85% for 14-16-year-olds, and 89-96% for adults, while rice/rice cereals contributed 31% for infants and smaller proportions in older groups.
Shows an association, not proof of cause and effect.
Tao SS, Bolger PM Food Addit Contam, 1999. PMID 10755138
1995 / Case report / outbreak investigation
In April 1995, two individuals in northwestern Iowa who had been drinking Kombucha tea daily for approximately 2 months experienced unexplained severe illness, resulting in one death. Following a preliminary investigation, the Iowa Department of Public Health recommended refraining from consuming Kombucha tea pending full evaluation. This report summarizes the joint investigation of these cases by state health authorities, the CDC, and the FDA.
Shows an association, not proof of cause and effect.
Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep, 1995. PMID 7476846
2016 / Narrative review
This review evaluates the therapeutic use of dried mushrooms and mushroom extracts, noting their longstanding presence in traditional Chinese medicine. It reports that there is currently no scientific evidence supporting the effectiveness of these preparations in treating human disease. The author highlights concerns regarding the potential harm of these products and urges critical evaluation of commercial claims. Controlled experiments and clinical trials are needed to explore useful secondary metabolites and develop this pharmacopeia.
Money NP Fungal Biol, 2016. PMID 27020147
2013 / Narrative review
This review evaluates the effect of white vegetable consumption (such as potatoes, cauliflowers, turnips, onions, parsnips, white corn, kohlrabi, and mushrooms) on glycemia, satiety, and food intake. The author notes that white vegetables vary widely in their contribution to energy, nutrient content, glycemia, and satiety. Using the potato as an example, the glycemic index can be misleading if not interpreted within the context of total dietary carbohydrate, nutrient composition, and satiety effects in typical meals. The review concludes that applying the glycemic index in isolation to judge white vegetables has led to premature and potentially counterproductive dietary guidance.
Anderson GH, Soeandy CD, Smith CE Adv Nutr, 2013. PMID 23674805
2006 / Narrative review of systematic reviews and clinical experiments
Beta-glucan is a polysaccharide fiber found in grains such as barley, oats, yeast, and mushrooms. The authors reviewed systematic reviews and clinical experiments evaluating the biomedical effects of beta-glucan, including lipid lowering, blood sugar reduction, weight reduction, immune modulation, and anticarcinogenic effects. The review aimed to identify issues and help develop future research strategies.
Kim SY, Song HJ, Lee YY, et al. J Korean Med Sci, 2006. PMID 17043406